Actuate Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOS CAPITAL MANAGEMENT, LP | 05/14/2025 | 9.89 M | $66.98 M | 0.00% | 50.74% |
| VOSS CAPITAL, LLC | 05/14/2025 | 142.38 K | $963.92 K | 157.72% | 0.73% |
| NORTHERN TRUST CORP | 05/13/2025 | 53.85 K | $364.58 K | 100.00% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 47.63 K | $322.48 K | 100.00% | 0.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 33.49 K | $226.72 K | 20.06% | 0.17% |
| NORTHWESTERN UNIVERSITY | 04/16/2025 | 27.78 K | $188.06 K | 0.00% | 0.14% |
| SIGMA PLANNING CORP | 05/02/2025 | 23.68 K | $160.28 K | 47.28% | 0.12% |
| VANGUARD GROUP INC | 05/09/2025 | 18.57 K | $125.75 K | 29.92% | 0.10% |
| ROYAL BANK OF CANADA | 05/15/2025 | 18.54 K | $126.00 K | 6,038.41% | 0.10% |
| MERCER GLOBAL ADVISORS INC /ADV | 05/15/2025 | 16.34 K | $110.65 K | 0.00% | 0.08% |
| MARSHALL WACE, LLP | 05/15/2025 | 16.11 K | $109.09 K | 100.00% | 0.08% |
| CITADEL ADVISORS LLC | 05/15/2025 | 14.19 K | $96.03 K | 100.00% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 12.19 K | $82.49 K | 100.00% | 0.06% |
| KG&L CAPITAL MANAGEMENT,LLC | 04/23/2025 | 12.00 K | $81.24 K | 0.00% | 0.06% |
| SFMG, LLC | 05/09/2025 | 11.00 K | $74.47 K | 100.00% | 0.06% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 05/09/2025 | 10.37 K | $96.40 K | 100.00% | 0.05% |
| FREESTONE CAPITAL HOLDINGS, LLC | 05/13/2025 | 10.00 K | $67.70 K | 0.00% | 0.05% |
| BLACKROCK, INC. | 05/02/2025 | 7.60 K | $51.44 K | -1.90% | 0.04% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 3.13 K | $21.16 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.56 K | $17.30 K | 100.00% | 0.01% |
| UBS GROUP AG | 05/13/2025 | 1.98 K | $13.40 K | 2.33% | 0.01% |
| MORGAN STANLEY | 05/15/2025 | 1.54 K | $10.41 K | 183.76% | 0.01% |
| CITIGROUP INC | 05/12/2025 | 649 | $4.39 K | 32,350.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 25 | $169 | 4.17% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 04/29/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Actuate Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Actuate Therapeutics Inc. The most heavily invested institutionals were:
BIOS Capital Management, LP: 9.89 M
Voss Capital, LLC: 142,381
NORTHERN TRUST CORP: 53,852
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 47,634
GEODE CAPITAL MANAGEMENT, LLC: 33,489
NORTHWESTERN UNIVERSITY: 27,778
53.35% of Actuate Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 10.38 M shares in the last 24 months. This purchase volume represents approximately $64.35 M in transactions.